Speaker illustration

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation -application of CHA2DS2-VASc and HAS-BLED scores-

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiogenic Embolism

Session: Stroke ePosters

Thumbnail

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertrophic Cardiomyopathy

Session: Congress committee e-posters choice in arrhythmias and device therapy

Thumbnail

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Epidemiology of atrial fibrillation

Thumbnail

Impact of subclinical atrial fibrillation detected by cardiac implantable electronic devices on the risk of future embolic stroke events from Far East

Event: ESC CONGRESS 2019

Topic: Cardiogenic Embolism

Session: Heart and brain interaction - Stroke

Thumbnail

Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East

Event: ESC Congress 2018

Topic: Cardiogenic Embolism

Session: Adverse kidney infections and other complications after coronary interventions

Thumbnail

Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate

Event: ESC Congress 2018

Topic: Risk Factors and Risk Assessment

Session: Ventricular arrhythmias and SCD. Epidemiology, prognosis, outcome

Thumbnail

Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices

Event: ESC CONGRESS 2017

Topic: Stroke

Session: Interventions, peripheral circulation, stroke, surgery - Miscellaneous

Thumbnail

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Session: Sudden cardiac death and implantable defibrillators

Thumbnail

Risk classification for sudden cardiac death in japanese hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator in comparison between aha, jcs and esc guideline.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Documents, Guidelines & Highlights

Session: Scientific documents and Guidelines

Thumbnail

Prognosis of cardiac sarcoidosis in japanese patients with implantable cardioverter defibrillator -with versus without other organ involvement -

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Others (Cardiac arrhythmias, non invasive)

Session: ECG and eCardiology

Thumbnail

This platform is supported by

logo Novo Nordisk